The BRCA gene test is most often a blood test. A doctor, nurse or medical technician inserts a needle into a vein, usually in your arm, to draw the blood sample needed for testing. Your blood sample then goes to a lab for DNA analysis.
In some cases, other sample types are collected for DNA analysis, including saliva. If you have a family history of cancer and are interested in pursuing a saliva DNA test, discuss it with your doctor. He or she can refer you to a genetic counselor who can determine the most appropriate sample type for genetic testing.
It takes several weeks before test results are available. You meet with your genetic counselor to learn your test results, discuss their implications and go over your options. Federal and state laws help ensure the privacy of your genetic information and protect against discrimination in health insurance and employment.
Sept. 01, 2016
- BRCA1 and BRCA2: Cancer risk and genetic testing. National Cancer Institute. http://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet. Accessed June 3, 2016.
- Peshkin BN, et al. Genetic counseling and testing for hereditary breast and ovarian cancer. http://www.uptodate.com/home. Accessed June 3, 2016.
- AskMayoExpert. Genetic testing for BRCA1 and BRCA2 mutations. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2014.
- U.S. Preventive Services Task Force. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: Recommendation statement. American Family Physician. 2015;91:118A.
- Peshkin BN, et al. BRCA1 and BRCA2-associated hereditary breast and ovarian cancer. http://www.uptodate.com/home. Accessed June 3, 2016.
- Niederhuber JE, et al., eds. Genetic factors: Hereditary cancer predisposition syndromes. In: Abeloff’s Clinical Oncology. 5th ed. Philadelphia, Pa.: Churchill Livingstone Elsevier; 2014. http://www.clinicalkey.com. Accessed June 3, 2016.
- Raby BA, et al. Genetic counseling and testing. http://www.uptodate.com/home. Accessed June 3, 2016.
- Isaacs C, et al. Management of patients at high risk for breast and ovarian cancer. http://www.uptodate.com/home. Accessed June 3, 2016.
- Stan DL, et al. Challenging and complex decisions in the management of the BRCA mutation carrier. Journal of Women's Health. 2013;22:825.
- Pruthi S (expert opinion). Mayo Clinic, Rochester, Minn. July 20, 2016.
- Brendish KH (expert opinion). Mayo Clinic, Phoenix/Scottsdale, Ariz. July 20, 2016.
- Genetic/familial high-risk assessment: Breast and ovarian. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed July 20, 2016.
BRCA gene test for breast and ovarian cancer risk